Israel Englander Ab Cellera Biologics Inc. Transaction History

Millennium Management LLC

$192 Billion
Q4 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Ab Cellera Biologics Inc. stock. As of the latest transaction made, Millennium Management LLC holds 1,482,715 shares of ABCL stock, worth $4.85 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,482,715

Previous 753,887 96.68%

Holding current value

$4.85 Million

Previous $1.95 Million 122.54%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$2.48 - $3.15 $1.81 Million - $2.3 Million	728,828 Added 96.68%	1,482,715 $4.34 Million
Q3 2024 Nov 14, 2024	BUY	$2.39 - $3.49 $724,640 - $1.06 Million	303,197 Added 67.27%	753,887 $1.95 Million
Q2 2024 Aug 14, 2024	SELL	$2.73 - $4.73 $2.23 Million - $3.87 Million	-817,328 Reduced 64.46%	450,690 $1.33 Million
Q1 2024 May 15, 2024	BUY	$4.29 - $5.97 $54,907 - $76,410	12,799 Added 1.02%	1,268,018 $5.74 Million
Q4 2023 Feb 14, 2024	SELL	$3.91 - $5.93 $7.87 Million - $11.9 Million	-2,012,399 Reduced 61.59%	1,255,219 $7.17 Million
Q2 2023 Aug 14, 2023	BUY	$5.66 - $7.59 $11.7 Million - $15.6 Million	2,060,920 Added 170.79%	3,267,618 $21.1 Million
Q1 2023 May 15, 2023	BUY	$7.31 - $11.18 $5.7 Million - $8.71 Million	779,150 Added 182.24%	1,206,698 $9.1 Million
Q4 2022 Feb 14, 2023	SELL	$9.48 - $14.52 $4.19 Million - $6.41 Million	-441,756 Reduced 50.82%	427,548 $4.33 Million
Q3 2022 Nov 14, 2022	SELL	$9.2 - $13.68 $19.2 Million - $28.6 Million	-2,087,340 Reduced 70.6%	869,304 $8.6 Million
Q2 2022 Aug 15, 2022	BUY	$5.72 - $10.65 $8.37 Million - $15.6 Million	1,462,648 Added 97.9%	2,956,644 $31.5 Million
Q1 2022 May 16, 2022	BUY	$7.46 - $14.14 $5.95 Million - $11.3 Million	797,635 Added 114.54%	1,493,996 $14.6 Million
Q4 2021 Feb 14, 2022	SELL	$12.99 - $17.73 $1.97 Million - $2.69 Million	-151,458 Reduced 17.86%	696,361 $9.96 Million
Q3 2021 Nov 15, 2021	BUY	$14.85 - $21.34 $11.6 Million - $16.7 Million	782,162 Added 1191.29%	847,819 $17 Million
Q2 2021 Aug 16, 2021	BUY	$20.19 - $34.17 $833,221 - $1.41 Million	41,269 Added 169.22%	65,657 $1.44 Million
Q1 2021 May 17, 2021	SELL	$23.29 - $53.2 $1.68 Million - $3.84 Million	-72,168 Reduced 74.74%	24,388 $828,000
Q4 2020 Feb 16, 2021	BUY	$39.0 - $58.9 $3.77 Million - $5.69 Million	96,556 New	96,556 $3.89 Million

Others Institutions Holding ABCL

# of Institutions

168

Shares Held

120M

Call Options Held

176K

Put Options Held

265K

View Full List

About AbCellera Biologics Inc.

Ticker ABCL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 285,139,008
Market Cap $932M
Description
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...

More about ABCL

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account